Bolt Biotherapeutics Inc (BOLT)

$0.76

Market is closed - opens 7 PM, 30 May 2024

Performance

  • $0.76
    $0.76
    $0.76
    downward going graph

    0.53%

    Downside

    Day's Volatility :1.12%

    Upside

    0.6%

    downward going graph
  • $0.73
    $1.81
    $0.76
    downward going graph

    3.41%

    Downside

    52 Weeks Volatility :59.44%

    Upside

    58.01%

    downward going graph

Returns

PeriodBolt Biotherapeutics Inc
3 Months
-33.33%
6 Months
-10.9%
1 Year
-55.56%
3 Years
-95.42%

Highlights

Market Capitalization
29.0M
Book Value
$2.96
Earnings Per Share (EPS)
-1.6
Wall Street Target Price
1.25
Profit Margin
0.0%
Operating Margin TTM
-946.19%
Return On Assets TTM
-24.57%
Return On Equity TTM
-48.69%
Revenue TTM
7.9M
Revenue Per Share TTM
0.21
Quarterly Revenue Growth YOY
48.1%
Gross Profit TTM
1.6M
EBITDA
-74.3M
Diluted Eps TTM
-1.6
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-1.35
EPS Estimate Next Year
-1.19
EPS Estimate Current Quarter
-0.51
EPS Estimate Next Quarter
-0.48

Analyst Recommendation

Buy
    83%Buy
    16%Hold
    0
    0%Sell
Based on 12 Wall street analysts offering stock ratings for Bolt Biotherapeutics Inc(by analysts ranked 0 to 5 stars)
Based on 12 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
10
Hold
2
2
2
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 64.47%

Current $0.76
Target $1.25

Technicals Summary

Sell

Neutral

Buy

Bolt Biotherapeutics Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin

Institutional Holdings

  • Vivo Capital, LLC

    9.24%
  • TANG CAPITAL MANAGEMENT LLC

    8.97%
  • Sofinnova Ventures

    7.22%
  • Pivotal bioVenture Partners Investment Advisor LLC

    4.96%
  • Newtyn Management LLC

    4.46%
  • Orbimed Advisors, LLC

    4.04%

Company Information

bolt biotherapeutics is a start-up with compelling technology from dr. engleman’s lab at stanford university, which demonstrated complete cures in numerous cancer models. the company is backed by strong life sciences investors and is early in its growth curve, seeking bright, highly motivated individuals that will be the company’s future leaders to help it further develop and bring to patients novel and curative biotherapies.

Organization
Bolt Biotherapeutics Inc
Employees
100
CEO
Dr. Randall C. Schatzman Ph.D.
Industry
Healthcare

FAQs